Maxim Pharmaceuticals
Organization
Trials
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
Phase 3, Completed, 360 people, Jun 3, 2004
Phase 3, Status unknown, Jan 27, 2003
Sources: clinicaltrials.gov
Organization
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
Phase 3, Completed, 360 people, Jun 3, 2004
Phase 3, Status unknown, Jan 27, 2003
Sources: clinicaltrials.gov